Charles River presents

Innovate South West 2025: Advancing Drug Development

Join us on Wednesday 21st May 2025 for our annual networking event, hosted at Charles River Labs in Portishead. This is a fantastic opportunity to connect with fellow businesses and interact with our cell biology, immunology, infection, and pharmacology experts. We’ve lined up an exciting agenda and can’t wait to welcome you on-site. This year, we have a diverse range of internal and external speakers, poster sessions, and the chance to see live lab demonstrations and cutting-edge equipment.


Talk to us about:

•    Immuno-oncology

•    Autoimmunity

•    Inflammation and allergy

•    Infectious disease (bacterial, viral, fungal)

•    Bespoke cell biology assays (validation, optimization, transfer)

•    In vitro efficacy studies

•    Pharmacology studies

•    Clinical biomarker analysis


From small molecules to large molecules, cell therapies, RNA therapeutics, and vaccines, let’s discuss pioneering solutions for your drug development.


Agenda:

10:30 – 10:45 Registration and pastries*

10:45 - 12:00 Morning session of talks

12:00 - 13:00 Lunch* with poster session & networking

13:00 – 14:15 Lab tours and equipment demos

14:30 - 15:30 Afternoon session of talks

15:30 - 16.00 Close and refreshments*

*Lunch and refreshments will be provided


When: Wednesday 21st May 2025, 10.30am - 4.00pm


Where: Discovery House, Conference Avenue, Quays Office Park, Portishead, BS20 7LZ


Register below. After you register, we will email you confirmation with the event details and agenda.


By submitting this form, Charles River will use the personal data you provide to handle your request. I understand that I can unsubscribe at any time. Read our privacy notice for more information.

Suggestions for therapeutic areas: immune-oncology, immunology, autoimmune, infection, inflammation, neuroinflammation


Suggestions for types of studies: in vitro characterization, in vitro derisking studies, GCLP, biomarkers, PK/PD, IO models, autoimmune models;


Suggestions for modality: small molecule, antibody and antibody associated therapeutics, cell therapy, gene therapy, RNA therapeutic, vaccine, microbiome/LBP